How to leverage technologies for the discovery of new Vaccines
Posted on August 19, 2013
By: Andrew Natenshon, Head China Research Strategy and Operations
Novartis Vaccines & Diagnostics
Introduction New technologies are a key element in developing innovative vaccines, however managing research and providing the right structures to allow these innovative technologies to flourish is not trivial. Organisations need to be setup to maximise the opportunity to develop and nurture these ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
